Austrian Left Atrial Appendage Closure Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Graz
About this trial
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
Eligibility criteria
Qualifiers
Patients who received LAAC in Austria
Disqualifiers
Absence of informed consent
Trial design
Treatments tested in this trial
- LAAC
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov